Mechanisms and therapeutic implications of hypermutation in gliomas M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ... Nature 580 (7804), 517-523, 2020 | 494 | 2020 |
Mitochondrial quality control during inheritance is associated with lifespan and mother–daughter age asymmetry in budding yeast JR McFaline‐Figueroa, J Vevea, TC Swayne, C Zhou, C Liu, G Leung, ... Aging cell 10 (5), 885-895, 2011 | 235 | 2011 |
Brain tumors JR McFaline-Figueroa, EQ Lee The American journal of medicine 131 (8), 874-882, 2018 | 233 | 2018 |
Role for cER and Mmr1p in anchorage of mitochondria at sites of polarized surface growth in budding yeast TC Swayne, C Zhou, IR Boldogh, JK Charalel, JR McFaline-Figueroa, ... Current Biology 21 (23), 1994-1999, 2011 | 117 | 2011 |
Deep‐learning detection of cancer metastases to the brain on MRI M Zhang, GS Young, H Chen, J Li, L Qin, JR McFaline‐Figueroa, ... Journal of Magnetic Resonance Imaging 52 (4), 1227-1236, 2020 | 105 | 2020 |
The viral connection to glioblastoma JR McFaline-Figueroa, PY Wen Current infectious disease reports 19, 1-5, 2017 | 48 | 2017 |
Evaluation of standard response assessment in neuro-oncology, modified response assessment in neuro-oncology, and immunotherapy response assessment in neuro-oncology in newly … G Youssef, R Rahman, C Bay, W Wang, MJ Lim-Fat, O Arnaout, WL Bi, ... Journal of Clinical Oncology 41 (17), 3160-3171, 2023 | 25 | 2023 |
when less is more: dexamethasone dosing for brain tumors MJ Lim-Fat, WL Bi, J Lo, EQ Lee, MS Ahluwalia, TT Batchelor, SM Chang, ... Neurosurgery 85 (3), E607-E608, 2019 | 23 | 2019 |
Clinical utility of targeted next-generation sequencing assay in IDH-wildtype glioblastoma for therapy decision-making MJ Lim-Fat, GC Youssef, M Touat, JB Iorgulescu, S Whorral, M Allen, ... Neuro-oncology 24 (7), 1140-1149, 2022 | 21 | 2022 |
A pilot study of axicabtagene ciloleucel (axi-cel) for the treatment of relapsed/refractory primary and secondary central nervous system lymphoma (CNSL) CA Jacobson, C Falvey, R Bouvier, S Hogan, E Kendricken, J Jones, ... Blood 140 (Supplement 1), 1060-1061, 2022 | 20 | 2022 |
Divergent roles of PI3K isoforms in PTEN-deficient glioblastomas S Xie, J Ni, JR McFaline-Figueroa, Y Wang, RT Bronson, KL Ligon, ... Cell reports 32 (13), 2020 | 19 | 2020 |
Telomerase inhibition is an effective therapeutic strategy in TERT promoter-mutant glioblastoma models with low tumor volume E Aquilanti, L Kageler, J Watson, DM Baird, RE Jones, M Hodges, ... Neuro-oncology 25 (7), 1275-1285, 2023 | 17 | 2023 |
Inaugural results of the individualized screening trial of innovative glioblastoma therapy: a phase II platform trial for newly diagnosed glioblastoma using Bayesian adaptive … R Rahman, L Trippa, EQ Lee, I Arrillaga-Romany, G Fell, M Touat, ... Journal of Clinical Oncology 41 (36), 5524-5535, 2023 | 13 | 2023 |
A low percentage of metastases in deep brain and temporal lobe structures TK Yanagihara, JR McFaline-Figueroa, NJ Giacalone, AW Lee, V Soni, ... Neuro-oncology 21 (5), 640-647, 2019 | 11 | 2019 |
Negative trials over and over again: How can we do better? JR McFaline-Figueroa, PY Wen Neuro-oncology 25 (1), 1-3, 2023 | 10 | 2023 |
Brain MRS glutamine as a biomarker to guide therapy of hyperammonemic coma AH O'Donnell-Luria, AP Lin, SK Merugumala, F Rohr, SE Waisbren, ... Molecular Genetics and Metabolism 121 (1), 9-15, 2017 | 10 | 2017 |
CTNI-12. Preliminary results of the abemaciclib arm in the individualized screening trial of innovative glioblastoma therapy (INSIGHT): a phase II platform trial using Bayesian … P Wen, L Trippa, E Lee, G Fell, R Rahman, I Arrillaga-Romany, M Touat, ... Neuro-oncology 22 (Supplement_2), ii44-ii44, 2020 | 8 | 2020 |
Biology and treatment of meningiomas: a reappraisal JR McFaline-Figueroa, TJ Kaley, IF Dunn, WL Bi Hematology/Oncology Clinics 36 (1), 133-146, 2022 | 5 | 2022 |
Defects in mitochondrial distribution during the prolonged lag phase of Saccharomyces cerevisiae preceding growth in glycerol as the sole source of carbon J McInnes, M Rehders, JR McFaline-Figueroa, K Brix, LA Pon, E Nevoigt FEMS Yeast Research 13 (7), 706-710, 2013 | 5 | 2013 |
Ctni-05. Preliminary results of the neratinib arm in the individualized screening trial of innovative glioblastoma therapy (Insight): a phase II platform trial using bayesian … I Arrillaga-Romany, L Trippa, G Fell, EQ Lee, R Rahman, M Touat, ... Neuro-Oncology 23 (Supplement_6), vi59-vi59, 2021 | 4 | 2021 |